Tekla Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. It invests in public equity markets worldwide, focusing on life sciences companies in areas such as biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, healthcare IT and services, devices and supplies, as well as agriculture and environmental management. The fund primarily targets growth stocks of small-cap companies and uses fundamental analysis, considering factors such as market position, management experience, technological expertise, and funding ability. It benchmarks performance against the NASDAQ Biotech Index and the S&P 500 Index. Formed on February 20, 1992, the fund is domiciled in the United States.